Suresnes

SURESNES, France and MONTRAL, November 8, 2011 - Les Laboratoires Servier, France (Servier) and Prognomix Inc., Canada(Prognomix) announced today that they have entered into a research and development agreement aimed at identifying novel targets as part of programs meant to develop innovative type 2 diabetes and metabolic disease treatment.